Invasive group B streptococcal infections in Western Australia, 2000-2018
- PMID: 39780516
- PMCID: PMC11900862
- DOI: 10.1111/imj.16611
Invasive group B streptococcal infections in Western Australia, 2000-2018
Abstract
Background: Neonatal and puerperal sepsis are major manifestations of invasive group B streptococcal (Streptococcus agalactiae; iGBS) infections. International data indicate the importance of iGBS infections among non-pregnant adults.
Aims: To describe the burden of iGBS infections in Western Australia (WA) between 2000 and 2018 in terms of incidence, length of hospitalisation and all-cause 30- and 90-day mortality.
Methods: This was a retrospective, population-based study using linked data from the state government-owned pathology provider, hospitalisations and death registrations. Children and adults with isolation of GBS in a normally sterile site or a hospital-based diagnosis of iGBS infection were included.
Results: There were 2861 cases; just over a quarter (n = 768) were aged 0-1 year. Half of the cases were among females (1438 of 2861), and the median age was 39 years. Incidence increased over the study period, with an age- and sex-adjusted incidence rate ratio for year of 1.08 (95% confidence interval (CI) 1.06-1.09). The incidence in 2018 was 9.5 cases (95% CI 8.3-10.6 cases) per 100 000 population. The proportion of cases among those aged 0-1 year fell across the period, while the relative incidence in older age groups increased. The median length of hospital stay was 7 days (interquartile range 4-15 days), and mortality at 30 days was 3% (95 of 2861).
Conclusions: iGBS cases increased across the period 2000-2018 in WA, with older adults making up a higher proportion of cases over time. Preventive efforts among older patients, including potentially through vaccination, may reverse this increase.
Keywords: group B streptococcus; infectious disease; invasive disease; public health; streptococcus.
© 2025 The Author(s). Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians.
Figures
), Invasive group B streptococcal disease; (
), confirmatory pathology sample.
), Invasive group B streptococcal disease; (
), microbiological confirmation.
), Indigenous; (
), non‐indigenous.References
-
- Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000; 342: 15–20. - PubMed
-
- King Edward Memorial Hospital Obstetrics and Gynaecology Directorate . Clinical Practice Guideline: Group B Streptococcus . Perth: Government of Western Australia, North Metropolitan Health Service; 2021.
-
- Farley MM, Harvey RC, Stull T, Smith JD, Schuchat A, Wenger JD et al. A population‐based assessment of invasive disease due to group B streptococcus in nonpregnant adults. N Engl J Med 1993; 328: 1807–1811. - PubMed
-
- Wright CM, Langworthy K, Manning L. The Australian burden of invasive group a streptococcal disease – a narrative review. Intern Med J 2020; 51: 835–844. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
